CPH — Cipher Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$223.35m
- CA$168.99m
- $21.16m
- 97
- 69
- 100
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.64 | 4.39 | 7.76 | 26.6 | 20.4 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 3.44 | 5.79 | 0.791 | 0.294 | 0.402 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.618 | 1.72 | 4.68 | -3.03 | -3.28 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 7.93 | 11.7 | 13.8 | 10.6 | 16 |
Capital Expenditures | -1.31 | -0.76 | 0 | -0.081 | -0.144 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.153 | 0 | — | — | — |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Cash from Investing Activities | -1.46 | -0.76 | 0 | -0.081 | -0.144 |
Financing Cash Flow Items | -0.744 | -0.163 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -10.5 | -8.13 | -2.47 | -1.91 | -5.24 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -4.01 | 2.8 | 11.4 | 8.29 | 11 |